Gastrectomy Clinical Trials

Clinical trials related to Gastrectomy Procedure

Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to identify pre-operative phenotypic determinants predictive of quality of life trajectories in post-bariatric surgery patients. In addition, this study will have as a secondary objective the highlighting of a potential link between post-surgery quality of life trajectories and those of anxiety/depression scores, eating behaviors and body mass indices. This study will be conducted during the usual care of patients undergoing the GEROM73 program, lasting a total of 30 months. The GEROM73 program includes care for the six months preceding bariatric surgery and the 24 months following surgery. This program supports patients throughout their bariatric care.. Throughout the GEROM73 program, patients will complete questionnaires on anxiety, depression, eating disorders, Impact of Weight on Quality Of Life. Patients' weight, body mass index and body schema will also be measured throughout the GEROM program.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• patient \> 18years old

• Integrated into the GEROM73 surgical program and starting the intra-hospital program

Locations
Other Locations
France
Centre Hospitalier Métropole Savoie
RECRUITING
Chambéry
Contact Information
Primary
Fabienne PRIEUR
urc@ch-metropole-savoie.fr
+33(0)479965999
Time Frame
Start Date: 2025-06-17
Estimated Completion Date: 2030-09-09
Participants
Target number of participants: 165
Treatments
Experimental: phenotype of patients during the GEROM73 program
Anxiety, Depression, Eating disorders, Impact of Weight on Quality Of Life.Patients' weight, Body Mass index and Body schema
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Metropole Savoie

This content was sourced from clinicaltrials.gov